Side Area
Latest Posts

Too many times Dr. Martin Makary has had to explain to a patient why he can't prescribe the drug he or she needs. On a weekly if not daily basis, doctors like Makary have to navigate around drug shortages caused by a manufacturing hang-up, recall or an unexpected price hike. They must search for alternative therapies, which may not be as effective, trusted or affordable. Clinicians are often in the dark about whether the shortage

Healthcare quality analysts say favoritism toward incumbents and fear of disrupting the status quo are major reasons why the same groups are repeatedly selected to develop and maintain CMS' quality measures. It's easier for incumbents to be selected over newcomers because of how the contracts are designed, said Francois de Brantes, senior vice president of commercial business development at healthcare consultancy Remedy Partners. The contracts the CMS uses for quality measure development are called umbrella